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The gene encoding the transcriptional coactivator peroxisome proliferator-activated receptor-c coactivator-1a (PGC-1a)
was targeted in mice. PGC-1a null (PGC-1a
 / ) mice were viable. However, extensive phenotyping revealed multi-system
abnormalities indicative of an abnormal energy metabolic phenotype. The postnatal growth of heart and slow-twitch
skeletal muscle, organs with high mitochondrial energy demands, is blunted in PGC-1a
 / mice. With age, the PGC-1a
 / 
mice develop abnormally increased body fat, a phenotype that is more severe in females. Mitochondrial number and
respiratory capacity is diminished in slow-twitch skeletal muscle of PGC-1a
 /  mice, leading to reduced muscle
performance and exercise capacity. PGC-1a
 /  mice exhibit a modest diminution in cardiac function related largely to
abnormal control of heart rate. The PGC-1a
 / mice were unable to maintain core body temperature following exposure
to cold, consistent with an altered thermogenic response. Following short-term starvation, PGC-1a
 /  mice develop
hepatic steatosis due to a combination of reduced mitochondrial respiratory capacity and an increased expression of
lipogenic genes. Surprisingly, PGC-1a
 /  mice were less susceptible to diet-induced insulin resistance than wild-type
controls. Lastly, vacuolar lesions were detected in the central nervous system of PGC-1a
 /  mice. These results
demonstrate that PGC-1a is necessary for appropriate adaptation to the metabolic and physiologic stressors of
postnatal life.
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Introduction
Mitochondrial functional capacity is dynamically regulated
to meet the diverse energy demands imposed on the
mammalian organism following birth. Postnatal mitochon-
drial biogenesis involves multiple signaling and transcrip-
tional regulatory pathways that control the coordinate
expression of nuclear and mitochondrial genes involved in
mitochondrial structure, metabolism, and proliferation [1].
Recent evidence points toward a transcriptional coactivator,
peroxisome proliferator-activated receptor-c (PPARc) coac-
tivator-1a (PGC-1a), as an integrator of the molecular
regulatory circuitry involved in the transcriptional control
of cellular energy metabolism, including mitochondrial
function and biogenesis [1,2]. PGC-1a was discovered in a
yeast two-hybrid screen for brown adipose-speciﬁc factors
that interact with the adipogenic nuclear receptor PPARc [2].
Subsequently, two additional PGC-1 family members were
identiﬁed, PGC-1 related coactivator (PRC) [3] and PGC-1b
[4,5]. PGC-1a serves as a direct transcriptional coactivator of
nuclear and nonnuclear receptor transcription factors
involved in cellular energy metabolism [6]. PGC-1a is distinct
among most coactivators in that it exhibits a tissue-enriched
expression pattern and is highly inducible by physiologic
conditions known to increase the demand for mitochondrial
ATP or heat production [2,6,7]. PGC-1a is enriched in brown
adipose tissue (BAT), heart, slow-twitch skeletal muscle, and
kidney—all tissues with high-capacity mitochondrial systems.
The expression of the gene encoding PGC-1a is rapidly
induced by cold exposure, short-term exercise, and fasting
[2,8,9,10,11,12,13,14,15]. These latter observations suggest
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metabolism.
Several lines of evidence, based on the results of over-
expression studies, indicate that PGC-1a is sufﬁcient to
promote mitochondrial biogenesis and regulate mitochon-
drial respiratory capacity. First, PGC-1a activates the tran-
scription of mitochondrial uncoupling protein-1 (UCP-1) in
BAT through interactions with the nuclear hormone recep-
tors PPARc and thyroid receptor [2]. Second, forced
expression studies in adipogenic and myogenic mammalian
cell lines demonstrated that PGC-1a activates mitochondrial
biogenesis through a group of transcription factor targets
including nuclear respiratory factors 1 and 2 (NRF-1 and -2)
and mitochondrial transcription factor A (Tfam), key tran-
scriptional regulators of mitochondrial DNA transcription
and replication [8]. Third, studies in primary cardiac
myocytes in culture and in the hearts of transgenic mice
have demonstrated that overexpression of PGC-1a promotes
mitochondrial biogenesis [10,16]. Lastly, forced expression of
PGC-1a in skeletal muscle of transgenic mice triggers
mitochondrial proliferation and the formation of mitochon-
drial-rich type I, oxidative (‘‘slow-twitch’’) muscle ﬁbers [17].
Collectively, these results indicate that PGC-1a is sufﬁcient to
drive mitochondrial biogenesis.
Recent evidence also implicates PGC-1a in the homeostatic
control of systemic energy metabolism. PGC-1a has been
shown to regulate several key hepatic gluconeogenic genes
[18,19,20,21]. Recent studies have also shown altered expres-
sion of PGC-1a and downstream mitochondrial target path-
ways in skeletal muscle of humans with insulin resistance and
diabetes [22,23,24]. In addition, single nucleotide polymor-
phisms within the human PGC-1a gene have been shown to be
associated with obesity, hypertension, and diabetes
[25,26,27,28,29,30].
The gain-of-function studies described to date provide
compelling evidence that PGC-1a is capable of regulating
postnatal energy metabolism. However, the necessity of PGC-
1a for energy metabolic homeostasis, mitochondrial bio-
genesis, development, and growth can only be addressed
using loss-of-function strategies. To this end, we have
established and characterized mice with targeted deletion of
the PGC-1a gene. Our studies of PGC-1a
 /  mice demonstrate
that PGC-1a is not absolutely required for prenatal viability
including mitochondrial biogenesis. However, our ﬁndings
indicate that the coactivator PGC-1a serves a critical role in
the normal metabolic function of multiple organs and for
appropriate adaptation to physiologic stress during postnatal
life.
Results
Disruption of the PGC-1a Gene in Mice
A neomycin-based gene targeting vector was generated to
delete exons 4 and 5 of the murine PGC-1a gene. The
targeting event resulted in a 39 homologous recombination
with insertion of the remainder of the construct (Figure 1A).
The insertion/recombination event was conﬁrmed by South-
ern blotting and DNA sequencing. The insertion caused an
exon 3 duplication between exons 5 and 6 that creates a
coding region frameshift resulting in a premature termina-
tion at amino acid 255. Germline transmission of the mutant
allele was conﬁrmed using Southern blotting (Figure 1B) and
PCR (unpublished data). The PGC-1a gene disruption resulted
in an unstable transcript that could not be detected by RNA
blot analysis in heart and other tissues in PGC-1a
 /  mice
(Figure 1C and unpublished data). Quantitative RT-PCR was
utilized to further evaluate the efﬁcacy of the gene targeting.
For these studies, PCR primers were designed to amplify a
region of the PGC-1a gene transcript containing the exon 5–6
border (predicted to be absent in PGC-1a
 /  mice) or the
exon 5–3 border (predicted to be present only in the PGC-
1a
 / mice). The exon 5–6 amplicon was detected in heart and
BAT of wild-type (WT) but not PGC-1a
 /  mice (Figure 1D).
Conversely, the exon 5–3 product was present only in PGC-
1a
 /  mice (Figure 1D). An exon 10–11 border amplicon
(predicted to be present in both genotypes) was detected in
WT and PGC-1a
 /  mice, but was greatly diminished in the
PGC-1a
 /  mice, indicating that the mutant transcript is
unstable. PGC-1a protein was not detected in whole cell
(Figure 1E) or nuclear protein extracts (unpublished data)
isolated from BAT of PGC-1a
 /  mice under basal conditions
or in response to cold exposure, a condition known to
markedly induce the expression of PGC-1a in BAT. Smaller
mutant PGC-1a proteins were also not detected by Western
blot analysis (unpublished data). Lastly, expression of the
genes encoding the other known PGC-1 family members,
PGC-1b and PRC, was not signiﬁcantly altered in heart of
PGC-1a
 /  mice (Figure 1C). Taken together, these results
support the conclusion that the gene targeting event resulted
in a PGC-1a null allele.
General Characteristics of the PGC-1a
 /  Mice: Age- and
Sex-Dependent Obesity
Heterozygous (PGC-1a
þ/ ) mice were bred to generate
PGC-1a
 /  offspring. The observed genotype ratios of the
offspring were consistent with the expected Mendelian ratios
(unpublished data). Unexpected deaths of the offspring were
not observed, and PGC-1a
þ/  and PGC-1a
 /  offspring
appeared normal. Total body weights obtained 1 wk after
birth revealed a 15%–20% reduction in total body mass for
male and female PGC-1a
 /  mice relative to sex-matched
PGC-1a
þ/þ littermates (Figure 2). The weight decrement
between PGC-1a
 /  and PGC-1a
þ/þ littermates disappeared
by 3 wk of age (Figure 2A). At 18 wk of age, body weight was
modestly but signiﬁcantly greater in male and female PGC-
1a
 /  mice compared to sex-matched PGC-1a
þ/þ controls
(Figure 2A). This weight difference was also signiﬁcant for
female PGC-1a
 /  mice at 24 wk of age (Figure 2A). The
abnormal weight gain in PGC-1a
 /  mice was not associated
with differences in food intake (unpublished data) or
alterations in general activity as monitored for 48 h (Figure
S1). Percent body fat, as determined by dual-energy X-ray
absorption (DEXA), was greater in 18- and 24-wk-old female
PGC-1a
 /  mice compared to age-matched female PGC-1a
þ/þ
counterparts, indicating that the body weight difference was
due, at least in part, to increased body fat (Figure 2A). Lean
mass was not signiﬁcantly different between the genotypes
(unpublished data). Although DEXA did not detect excess
body fat in male PGC-1a
 /  mice at 18 or 24 wk of age, older
male mutant mice (over 7 mo of age) accumulated more body
fat than male WT controls (Figure 2A and unpublished data).
Individual organ weights were assessed, given the impor-
tance of mitochondrial energy metabolism for postnatal
growth in certain organs. The weights of heart and slow-
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mius and soleus, but not the less oxidative tibialis anterior,
were signiﬁcantly lower in male and female PGC-1a
 /  mice
compared with age and sex-matched PGC-1a
þ/þ controls at 3
and 8 wk of age (Figure 2B and unpublished data). In contrast,
the weights of brain, liver, kidney, and BAT were not
signiﬁcantly different between the genotypes at the 3-wk
time point (Figure 2B). Thus, certain tissues with high
mitochondrial energy requirements, such as heart and slow-
twitch skeletal muscle, exhibit modest growth defects in PGC-
1a
 /  mice.
Abnormal Muscle Mitochondrial Phenotype in PGC-1a
 / 
Mice
General histologic analyses were performed to begin to
evaluate the mild growth defect found in postnatal heart and
skeletal muscle of the PGC-1a
 / mice. There were no obvious
abnormalities in cellularity, cell size, or extracellular matrix
in the tissues of 1–2-mo-old PGC-1a
 /  mice (unpublished
data). Given the important role of PGC-1a in mitochondrial
function and biogenesis, we examined mitochondrial ultra-
structure in the relevant tissues. Electron microscopic
analysis revealed fewer and smaller mitochondria in soleus
muscle of PGC-1a
 /  mice compared to sex- and age-
matched PGC-1a
þ/þ controls (Figure 3A). Quantitative
morphometry of the electron micrographs conﬁrmed that
the cellular volume density of soleus mitochondria was
signiﬁcantly lower in PGC-1a
 /  mice compared to PGC-
1a
þ/þ controls independent of changes in the myoﬁbrillar
component (Figure 3B). Consistent with a defect in mito-
chondrial biogenesis, we found a reduction in the expression
of nuclear genes encoding proteins involved in mitochon-
drial electron transport (cytochrome c and cytochrome
oxidase IV) and oxidative phosphorylation (beta subunit of
ATP synthase) in soleus muscle of PGC-1a
 /  mice compared
with PGC-1a
þ/þ controls. In addition, the expression of Tfam,
a known PGC-1a target involved in mitochondrial DNA
Figure 1. Deletion of the PGC-1a Gene
(A) Schematic of the gene targeting strategy. A region of the murine
PGC-1a gene containing exons 3–6 is shown schematically at the top.
Relevant restriction endonuclease sites are also shown. The targeting
construct containing a neomycin (Neo) cassette is shown below the
PGC-1a gene with dashed lines indicating the regions targeted for
homologous recombination. Homologous recombination between
the 39 end of the targeting vector and the PGC-1a gene is indicated by
the solid lines. The targeting construct inserted into the PGC-1a gene
resulting in a duplication of exon 3 and incorporation of the
targeting construct DNA into the ﬁnal recombinant as shown. Probes
used for the Southern blot studies and relevant restriction fragments
predicted by digestion of the recombinant are also shown.
(B) Southern blot analysis of embryonic stem cells (ESC) (digested
with Xba1) and tail DNA (digested with Pst1) is shown. The blots were
hybridized with the probes shown in Figure 1A. Results for PGC-1a
þ/þ
(þ/þ), PGC-1a
þ/  (þ/ ), and PGC-1a
 /  ( / ) genotypes are shown as
denoted at the bottom.
(C) Northern blot analysis using RNA isolated from the hearts of the
three relevant PGC-1a genotypes (as in Figure 1B) is shown using
PGC-1a cDNA as a probe. In addition, PGC-1b and PRC cDNA probes
were used as shown. Ethidium bromide staining of 18S ribosomal
RNA is shown at the bottom.
(D) Quantitative real time RT-PCR (Sybr green) was used to detect
PGC-1a transcripts using primer sets crossing different exon borders
as denoted. The exon 5–3 primer set detects only the mutant
transcript ( / ), whereas the exon 5–6 primer set detects only the WT
transcript. The values represent arbitrary units for RNA isolated
from the tissues shown for the three amplicons comparing PGC-1a
þ/þ
and PGC-1a
 / . N.D. = not detectable. The exon 10–11 amplicon was
evaluated to assess levels of mutant versus WT transcripts. The values
represent arbitrary units normalized to actin control.
(E) Western blot analysis using whole-cell protein extracts prepared
from BAT under basal conditions and following exposure to 4 8C for
8 h. The signal shown was obtained with polyclonal anti-PGC-1a
antibody [10]. An epitope-tagged PGC-1a, overexpressed in neonatal
cardiac myocytes using an adenoviral vector (Ad-PGC-1a), is shown as
a positive control. The Ponceau S stain of the protein gel is shown at
the bottom.
DOI: 10.1371/journal.pbio.0030101.g001
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Metabolic Derangements in PGC-1a Deficiencyreplication/transcription, was diminished in PGC-1a
 /  sol-
eus, providing one potential mechanism for defective
mitochondrial biogenesis (Figure 3C). In contrast to the
results with soleus, no signiﬁcant differences in mitochon-
drial ultrastructure or volume density were noted in heart or
BAT of PGC-1a
 /  mice (unpublished data).
To determine whether mitochondrial function was altered
in the skeletal muscle of PGC-1a
 /  mice, mitochondrial
respiration rates were measured using tissue strips prepared
from soleus muscle. In soleus of PGC-1a
 /  mice, a signiﬁcant
defect in state 3 (ADP-stimulated) respiration, but not state 2
(basal), was detected using succinate as the substrate
(Figure 3D). State 4 respiration rates (in the presence of
oligomycin) were also similar between the genotypes, indicat-
ing that the coupling of respiration to ATP production was
not signiﬁcantly altered in PGC-1a
 /  mice. These results are
Figure 3. Abnormal Mitochondrial Phenotype in Slow-Twitch Skeletal
Muscle of PGC-1a
 /  Mice
(A) Representative electron micrograph of soleus muscle from 1-mo-
old female PGC-1a
þ/þ and PGC-1a
 /  mice.
(B) Quantitative morphometric measurements of the cellular volume
density for the mitochondrial (Mito) and myoﬁbrillar (Myo) fractions
based on analysis of electron micrographs (three sections from three
animals per group). The bars represent mean 6 SEM. * p , 0.05
compared to corresponding PGC-1a
þ/þ values.
(C) Gene expression data. The results of real-time PCR analysis of
nuclear and mitochondrial genes involved in various components of
mitochondrial metabolism and mitochondrial biogenesis: cyto-
chrome C (Cyto c), ATP synthase b, Tfam, and cytochrome oxidase
IV (COX IV). Eight littermate pairs were used for analysis at 1–2 mo
of age and normalized to the WT value, which was assigned a value of
100, in each case. * p , 0.05 compared to corresponding PGC-1a
þ/þ
values.
(D) Mitochondrial respiration rates as determined by oxygen
consumption (VO2) performed on saponin-permeabilized muscle
strips prepared from soleus of PGC-1a
þ/þ and PGC-1a
 /  mice (as
described in Materials and Methods). The results are based on six
female animals in each group, using succinate as a substrate in the
presence of rotenone. Mean values (6 SEM) are shown for state 2
(basal), state 3 (ADP-stimulated), and state 4 respiration (presence of
oligomycin).
DOI: 10.1371/journal.pbio.0030101.g003
Figure 2. Evidence for Tissue-Specific Growth Abnormalities and Mild
Sex-Limited, Age-Dependent Obesity in PGC-1a
 /  Mice
(A)Thebarsrepresenttotalbodyweightfortheagesindicatedformale
(left graph) and female (center graph) PGC-1a
þ/þand PGC-1a
 / mice.
The body weight (BW) of the 1-wk-old PGC-1a
 /  mice was
normalized to that of PGC-1a
þ/þ littermates, which was assigned a
value of 100 (left axis). For the 3-, 18-, and 24-wk time points, absolute
weights of PGC-1a
 /  mice were compared to age-matched controls
(right axis). Percent fat as determined by DEXA scanning for
PGC-1a
þ/þ and PGC-1a
 /  mice (right graph). The results represent
n = 4 (males) and n   11 (females) for each genotype at 24 wk.
* p , 0.05 compared to corresponding PGC-1a
þ/þ mice.
(B) The bars represent organ weights corrected to body weight for
3-wk-old male and female PGC-1a
þ/þ and PGC-1a
 /  mice. The error
bars represent 6 SEM. Results represent n   14 for each group.
* p , 0.05 compared to corresponding PGC-1a
þ/þ mice.
DOI: 10.1371/journal.pbio.0030101.g002
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mitochondrial volume density.
Altered Skeletal Muscle Function in PGC-1a
 /  Mice
The abnormality in mitochondrial number and respiratory
function in skeletal muscle led us to further evaluate the
skeletal muscle phenotype. As an initial step, we measured
locomotor activity levels over a 1-h period using a high-
resolution photobeam system. PGC-1a
 / male mice exhibited
a signiﬁcantly lower mean number of ambulations and
rearings during the hour compared to the PGC-1a
þ/þ age-
matched controls (Figure 4). However, an analysis of
exploratory behavior showed that the PGC-1a
 /  mice were
reluctant to go into the center of the ‘‘ﬁeld’’ compared to
controls. Speciﬁcally, PGC-1a
 /  mice made signiﬁcantly
fewer entries into, spent signiﬁcantly less time in, and
traveled a signiﬁcantly shorter distance in the central area
of the ‘‘ﬁeld,’’ although differences in distance traveled in the
peripheral zone of the ‘‘ﬁeld’’ was not signiﬁcantly different
between groups (Figure S2). These data suggest that the
general activity level may have been affected by the
reluctance of the PGC-1a
 /  mice to go into the central area
of the ﬁeld and thus remain in the periphery (thigmotaxis),
possibly reﬂecting altered emotionality such as increased
fear.
A battery of tests was performed to further evaluate the
general sensorimotor phenotype of the PGC-1a
 /  mice. No
differences were found between PGC-1a
 /  mice and PGC-
1a
þ/þ controls on the ledge, platform, walking initiation, and
608 and 908 inclined screen tests (unpublished data), suggest-
ing that several sensorimotor functions were intact in the
PGC-1a
 / mice. However, the PGC-1a
 / mice were unable to
remain on an inverted screen for as long as the PGC-1a
þ/þ
controls (Figure 4A). Since the groups did not differ on the
times it took to turn around and climb to the top of 608 and
908 inclined screens, the differences on the inverted screen
test suggest that impaired strength rather than deﬁcits in
coordination were responsible for these differences.
To further evaluate the skeletal muscle phenotype, exercise
capacity was assessed in the PGC-1a
 /  mice. To this end, the
PGC-1a
 /  mice were exercised on a motorized treadmill
apparatus using a run-to-exhaustion format. PGC-1a
 /  mice
(6–8 mo of age) exhibited a markedly reduced capacity to
sustain running exercise (PGC-1a
 /  mice, 64 6 6 s; age-
matched PGC-1a
þ/þ mice, 586 6 104 s; Figure 4B). The same
result was obtained with younger PGC-1a
 /  mice, i.e., at 3.5
mo of age (unpublished data). To quantify aerobic exercise
capacity, VO2max (maximum oxygen consumption, measured
in milliliters of oxygen per kilogram of body weight per
minute) was measured with the treadmill-running protocol
using indirect calorimetry. VO2max was signiﬁcantly lower for
the PGC-1a
 /  mice (120.9 6 2.0 ml O2   kg
 1   min
 1)
compared to PGC-1a
þ/þ controls (141.6 6 2.1 ml O2   kg
 1  
min
 1) (Figure 4B). To directly evaluate muscle fatigability,
the force response to repetitive stimulation of isolated soleus
muscle was determined. The capacity to generate force
following a series of tetani is dependent upon mitochondrial
ATP production. During the initial phase of the stimulation
period, there was no difference in force generation in
muscles isolated from PGC-1a
 /  mice and PGC-1a
þ/þ
controls. However, fatigue resistance index, deﬁned as the
percent of initial force generated following a 2-min series of
fatiguingcontractions,wassigniﬁcantlylowerinthePGC-1a
 / 
mice (14.6 6 1.5%) compared to PGC-1a
þ/þ controls (24.8 6
2.9%) (Figure 4C). These results, together with the observed
abnormalities in skeletal muscle mitochondrial structure and
function, indicate that PGC-1a is necessary for functional
adaptation of skeletal muscle to physiologic demands.
Functional Abnormalities in Hearts of PGC-1a
 /  Mice
PGC-1a expression is enriched in heart, a tissue that relies
Figure 4. PGC-1a
 /  Mice Exhibit an Abnormal Skeletal Muscle
Functional Phenotype
(A) Measures of general activity and muscle strength. General activity
levels were measured in 3.5-mo-old male PGC-1a
þ/þ(n = 8) and PGC-
1a
 /  (n = 11) mice using a photobeam system as described in
Materials and Methods. Total ambulations (left graph), and rearings
(center graph) provide a general measure of locomotor activity. Time
spent on an inverted screen (right graph) represents a general
measure of extremity muscle strength. The results from two trials are
shown. * p , 0.05 compared to corresponding PGC-1a
þ/þ.
(B) Exercise studies. Male 6–8-mo-old PGC-1a
 /  and PGC-1a
þ/þ mice
were subjected to a run-to-exhaustion protocol on a motorized
treadmill (left graph) as described in Materials and Methods. * p ,
0.001 compared to corresponding PGC-1a
þ/þvalues. VO2max measure-
ments were determined for 2-mo-old male mice for each genotype
using a motorized treadmill at an elevation of 150 m and indirect
calorimetry set-up (right graph) as described in Materials and
Methods. * p , 0.05 compared to corresponding PGC-1a
þ/þ values.
(C) Time course of fatigue following repeated stimulation of soleus
muscle is shown for 4-mo-old male PGC-1a
 /  (n = 5) and PGC-1a
þ/þ
(n = 5) mice (left graph). The mean percent force remaining at 2 min
(Fatigue Resistance Index) is shown (right graph). * p , 0.05
compared to corresponding PGC-1a
þ/þ values.
DOI: 10.1371/journal.pbio.0030101.g004
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pump function throughout the postnatal life of the mamma-
lian organism. Echocardiographic screening studies of PGC-
1a
 /  mice at ages 4–6 mo did not reveal any signiﬁcant
differences in chamber sizes or ventricular function com-
pared to WT controls (unpublished data). Cardiac functional
and metabolic reserve was evaluated using exercise echocar-
diographic stress testing (EST). Given that the exercise
capacity of PGC-1a
 /  mice is diminished, a series of
preliminary treadmill exercise studies were performed to
deﬁne a reasonable exercise duration for run-to-exhaustion
to be used as a target duration for the EST. Based on the
results of these studies, an EST regimen was performed in
which PGC-1a
þ/þ control animals were exercised for a
duration of 60 s to match the predicted average for the
PGC-1a
 /  mice (ages 6–8 mo). Echocardiographic images
were obtained immediately following 60 s of exercise for the
PGC-1a
þ/þ controls or at the point of exhaustion for PGC-
1a
 /  mice (mean 60 6 6.1 s, range 45–90 s). Echocardio-
graphic-determined left ventricular fractional shortening
and heart rate were monitored for the 10-min period
immediately post exercise. The mean heart rate of the
PGC-1a
 /  mice exhibited an inappropriate decline during
the post exercise period (Figure 5A). In addition, echocardio-
graphically determined left ventricular fractional shortening
was decreased in the PGC-1a
 /  mice, but not the PGC-1a
þ/þ
mice during the ﬁrst 4 min of the post exercise period
(Figure 5A).
The results of the EST did not distinguish between a
primary cardiac abnormality versus effects secondary to the
exhaustion caused by reduced exercise tolerance related to
skeletal muscle dysfunction. To directly assess cardiac
function, the hearts of PGC-1a
 /  and PGC-1a
þ/þ mice were
isolated and perfused in the working mode. Hearts isolated
from PGC-1a
 /  mice generated lower cardiac work (cardiac
output multiplied by peak systolic pressure) compared to
PGC-1a
þ/þmice at identical loading conditions (Table 1). This
reduction in cardiac work was due to a reduced cardiac
output (Table 1). The relative contribution of heart rate and
stroke volume to diminished cardiac output in the PGC-1a
 / 
mice could not be delineated, because both were decreased
but neither to a signiﬁcant degree (Table 1). To further
distinguish between abnormalities in heart rate and ven-
tricular function, in vivo hemodynamic response to the
b1,a1-adrenergic-selective agonist dobutamine was evaluated
using a miniaturized Millar catheter. The ventricular func-
tional response to dobutamine was similar in PGC-1a
þ/þ and
PGC-1a
 /  mice (Figure 5B, right graph). However, PGC-1a
 / 
mice exhibited a signiﬁcantly blunted heart rate response to
b-adrenergic stimulation (Figure 5B, left graph). Taken to-
gether with the EST, these results strongly suggest that the
PGC-1a
 /  hearts are unable to mount an appropriate
chronotropic response to exercise and other physiologic
stimuli that activate b-adrenergic input to the heart.
However, our results did not reveal evidence for contractile
dysfunction.
PGC-1a
 /  Mice Exhibit an Abnormal Thermogenic
Response
PGC-1a has been implicated as an inducible regulator of
mitochondrial respiratory uncoupling, an important source
of heat production in BAT [2]. To determine whether PGC-
1a is necessary for an appropriate thermogenic response,
PGC-1a
þ/þ and PGC-1a
 /  mice were subjected to cold
exposure (4 8C) for a 5-h period while core body temperature
was monitored. PGC-1a
 /  mice exhibited a markedly
abnormal drop in core temperature compared to the WT
controls (Figure 6A). Speciﬁcally, the mean decline in core
temperature was greater than 12 8C at the 5-h time point in
PGC-1a
 /  mice, compared to an approximately 3 8C
decrement in PGC-1a
þ/þ controls. Although this thermogenic
Figure 5. Abnormal Cardiac Response to Physiologic Stress in PGC-1a
 / 
Mice
(A) Exercise echocardiographic studies. PGC-1a
þ/þ (n = 4) and PGC-
1a
 /  (n = 8) female mice aged 6–8 mo were subjected to an exercise
protocol on a motorized treadmill. This protocol was designed such
that the PGC-1a
 / mice ran to exhaustion based on the results of the
exercise studies shown in Figure 4. Accordingly, an exercise regimen
of 60 s was used for both groups. The graphs depict the heart rate
(left graph) and echocardiographically-determined ventricular frac-
tional shortening (FS) as a percent (right graph). Responses were
monitored for 10 min immediately post exercise.
(B) In vivo hemodynamic response to the b1,a1-adrenergic agonist
dobutamine.MaleandfemalePGC-1a
þ/þ(n=6)andPGC-1a
 / (n=6)
mice at 10–12 wk of age were anesthetized and a 1.4-French Millar
catheter was placed through the carotid artery into the left ventricle
as described in Materials and Methods. Heart rate (left graph) and a
measurement of ventricular systolic performance, dP/dt (right graph),
were measured following infusion of dobutamine. * p , 0.05.
DOI: 10.1371/journal.pbio.0030101.g005
Table 1. Cardiac Hemodynamics Measured in Isolated Working
Hearts of PGC-1a
þ/þ and PGC-1a
 /  Mice
Measure PGC-1a
þ/þ PGC-1a
 / 
Cardiac work (ml   mm Hg   min
 1   10
 2) 8.35 6 0.57 5.94 6 0.63
a
Cardiac output (ml/min) 11.54 6 0.75 8.67 6 1.02
a
PSP (mm Hg) 72.08 6 1.51 69.34 6 1.55
Stroke volume (ml) 0.04 6 0.003 0.03 6 0.003
Heart rate (bpm) 303.00 6 17 260.00 6 19
Values represent mean 6 SEM.
a p , 0.05.
DOI: 10.1371/journal.pbio.0030101.t001
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was absent in older mice (unpublished data).
The histologic appearance and neutral lipid stores of BAT
were assessed as an initial step to characterize the thermo-
genic phenotype exhibited by PGC-1a
 / mice. Histologic and
lipid quantiﬁcation studies were performed. Electron micro-
scopic analyses indicated that the mitochondrial ultrastruc-
ture was similar in BAT isolated from PGC-1a
 /  and PGC-
1a
þ/þmice before and after cold exposure (unpublished data).
In addition, levels of BAT triglyceride were similar between
the two genotypes (unpublished data). UCP-1 is a cold-
inducible protein involved in mitochondrial respiratory
uncoupling to generate heat in BAT. UCP-1 gene tran-
scription is known to be activated by PGC-1a [2]. Surpris-
ingly, basal and cold-induced BAT UCP-1 mRNA levels were
similar in PGC-1a
þ/þ and PGC-1a
 /  mice (Figure 6B). These
results suggest that PGC-1a is not necessary for the induction
of the expression of UCP-1 with cold exposure, and that other
factors, such as reduced capacity for mitochondrial respira-
tion, likely contribute to the abnormal thermogenic response
in the PGC-1a
 /  mice.
Thermogenesis in rodents related to mitochondrial
uncoupling is under the control of b3-adrenergic receptor
coupled signaling. Accordingly, the in vivo oxygen con-
sumption response to b3-adrenergic stimulation was exam-
ined in PGC-1a
 /  mice. For these experiments, VO2 (oxygen
consumption) was measured following administration of the
b3-agonist BRL 37344 using indirect calorimetry. VO2 was
signiﬁcantly increased in response to BRL 3744 in PGC-1a
þ/þ
but not PGC-1a
 /  mice (Figure 6C). These results indicate
that the metabolic response of BAT to an acute stimulus
such as cold and/or b3-adrenergic stimulation is altered in
the PGC-1a null mice, likely related to reduced capacity for
mitochondrial respiratory uncoupling.
Fasting-Induced Hepatic Steatosis in PGC-1a
 /  Mice
Previous studies have implicated PGC-1a in several hepatic
metabolic functions including fatty acid oxidation and
gluconeogenesis [18,19,20,21]. Accordingly, the hepatic phe-
notype was evaluated under basal conditions and following a
24-h fast, a stimulus known to induce fatty acid oxidation and
gluconeogenic rates in liver. Under basal fed conditions, the
livers of the PGC-1a
 /  mice appeared grossly normal and did
not exhibit histologic abnormalities (unpublished data).
However, following a 24 h-fast, the PGC-1a
 /  mice exhibited
marked hepatic steatosis as determined by gross inspection,
oil red O staining, electron microscopy, and measurements of
liver triglyceride (TAG) levels (Figure 7). There were no
differences in plasma triglycerides or free fatty acids between
the genotypes in fed or fasted states (unpublished data). To
further investigate the mechanisms involved in the fasting-
induced hepatic steatotic response, hepatocytes were isolated
from PGC-1a
 /  mice and WT controls. Oleate loading
experiments revealed that the PGC-1a
 /  hepatocytes accu-
mulated neutral lipid to a signiﬁcantly greater extent than
the WT cells (Figure 8A).
3H-palmitate oxidation rates were
signiﬁcantly lower in PGC-1a
 /  hepatocytes compared to
Figure 6. PGC-1a
 /  Mice Exhibit an Abnormal Thermogenic Response
(A) PGC-1a
þ/þ (n = 15) and PGC-1a
 /  (n = 21) mice aged 28–37 d
were subjected to cold (4 8C). Core rectal temperature was monitored
over a 5-h period. The change in core temperature 6 SEM is shown
in the graph (left) as a function of time. * p , 0.05.
(B) Representative Northern blot analysis (blot and gel at top)
performed with RNA isolated from BAT to detect UCP-1 transcript at
baseline (RT) and after 5 h of exposure to cold (4 8C) (UCP1).
Ethidium bromide (Eth Br) staining of ribosomal RNA is shown as a
control. Quantitative real-time RT-PCR for UCP-1 transcript is
shown on the graph at the bottom. The values represent mean
arbitrary units normalized to a 36B4 transcript (control).
(C) Altered response to b3-adrenergic agonist. To evaluate the oxygen
consumption (VO2) in response to the stimulation of BAT uncoupled
respiration, the b3-adrenergic agonist BRL 37344 was administered to
littermate PGC-1a
þ/þ (n = 5) and PGC-1a
 /  (n = 5) female mice
followed by measurement of VO2 by indirect calorimetry. Mean 6
SEM VO2 is shown. * p , 0.05.
DOI: 10.1371/journal.pbio.0030101.g006
Table 2. Metabolic Gene Expression in Liver of Fed and Fasted
PGC-1a
þ/þ and PGC-1a
 /  Mice
Metabolic Gene PGC-1a
þ/þ PGC-1a
 / 
Fed Fasted Fed Fasted
L-CPT I 1.0 6 0.11 2.1 6 0.24
a 1.0 6 0.11 1.8 6 0.04
a
MCAD 1.0 6 0.17 1.8 6 0.22
a 0.9 6 0.14 1.6 6 0.22
a
SREBP-1c 1.0 6 0.16 0.2 6 0.04
a 1.1 6 0.08 0.8 6 0.15
b
SCD1 1.0 6 0.12 0.7 6 0.08
a 1.7 6 0.27
b 1.6 6 0.25
b
FAS 1.0 6 0.10 0.5 6 0.08
a 1.7 6 0.28 0.6 6 0.10
a
GPAT 1.0 6 0.13 0.9 6 0.05 1.0 6 0.11 0.87 6 0.07
DGAT 1.0 6 0.13 2.1 6 0.22
a 1.7 6 0.14
b 3.2 6 0.15
a,b
Values represent mean (6 SEM) (n   6 for each group) mRNA levels as determined by real-time RT-PCR corrected for
GAPDH signal intensity and normalized (to 1.0) to the value of fed PGC-1a
þ/þ mice.
a p , 0.05 versus fed mice of the same genotype.
b p , 0.05 versus PGC-1a
þ/þ mice of the same dietary treatment.
L-CPT I, liver-type carnitine palmitoyltransferase; MCAD, medium-chain acyl-CoA dehydrogenase; SREBP, sterol
regulatory element binding protein; SCD, steroyl-CoA desaturase; FAS, fatty acid synthase; GPAT, glycerol-3-
phosphate acyltransferase; DGAT, diacylglycerol acyltransferase.
DOI: 10.1371/journal.pbio.0030101.t002
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þ/þ hepatocytes under basal conditions and following
exposure to oleate (Figure 8B). Taken together, these latter
results indicate a cell-autonomous defect in PGC-1a
 / 
hepatocytes that results in an inability to maintain cellular
lipid balance in the context of increased delivery of lipid such
as occurs with fasting.
PPAR, a known regulator of hepatic mitochondrial fatty
acid oxidation enzyme gene expression, is a target for
coactivation by PGC-1a [31]. Therefore, we sought to
determine whether the steatotic phenotype of the PGC-
1a
 /  mice related to reduced expression of PPAR target
genes. To this end, a survey of candidate genes and gene
expression proﬁling experiments were performed. Surpris-
ingly, the hepatic expression of PPAR target genes involved
in cellular fatty acid and oxidation (MCPT and MCAD) were
not signiﬁcantly different between the genotypes under fed
or fasted conditions (Table 2). Next, we performed experi-
ments to determine whether the reduced capacity for fat
oxidation in the hepatocytes of the PGC-1a
 /  mice was
related to altered mitochondrial respiratory function.
Compared to the WT controls, PGC-1a
 /  hepatocytes
exhibited a modest but signiﬁcant reduction in both state
2 and state 3 respiration rates (Figure 8C). These results
identify one potential mechanism responsible for the
fasting-induced hepatic steatosis: reduced capacity for fat
oxidation due to mitochondrial respiratory dysfunction.
Although the liver gene expression proﬁling studies did not
reveal abnormalities in the fatty acid oxidation pathway in
the PGC-1a
 /  mice, several interesting differences in the
activity of the sterol regulatory element binding protein-1c
(SREBP-1c) pathway were noted. Speciﬁcally, the fasting-
mediated down-regulation of SREBP-1c and its target gene
stearoyl-CoA desaturase (SCD1), was abolished in PGC-1a
 / 
mice (Table 2). Furthermore, expression of the gene encoding
diglyceride acyltransferase (DGAT), which catalyzes the last
step in TAG synthesis, was activated at baseline and induced
by fasting to a greater level in PGC-1a
 / mice (Table 2). These
results suggest that, in addition to a defect in oxidation,
components of the TAG synthesis pathway are activated in
the PGC-1a
 /  mice. To evaluate this possibility directly, rates
of
3H-glycerol incorporation into TAG were determined in
isolated hepatocytes.
3H-TAG incorporation was increased
nearly 50% in hepatocytes isolated from PGC-1a
 /  mice
compared to PGC-1a
þ/þ controls (Figure 8D), conﬁrming that
TAG synthesis rates are increased in PGC-1a null hepato-
cytes, identifying a second potential mechanism contributing
to the fasting-induced hepatic steatosis.
Despite a Mild Obese Phenotype, Female PGC-1a
 /  Mice
Do Not Exhibit Insulin Resistance
Recent studies have suggested that speciﬁc PGC-1a single
nucleotide polymorphisms and haplotypes may inﬂuence the
development of insulin resistance and diabetes [27,30] and
that PGC-1 activity is diminished in insulin-resistant and
diabetic muscle [22,23]. Accordingly, peripheral glucose
disposal and insulin responsiveness were examined in PGC-
1a
 /  mice. Glucose tolerance testing of 2-mo-old male and
female mice revealed no signiﬁcant difference in blood
glucose excursion between PGC-1a
þ/þ and PGC-1a
 /  groups
(unpublished data). Given that older female PGC-1a
 /  mice
develop an increase in body fat stores, glucose tolerance and
insulin responsiveness were further evaluated in this group.
Figure 7. Fasting-Induced Hepatic Steatosis Develops in PGC-1a
 /  Mice
(A) The photograph depicts the development of a pale liver in PGC-1a
 /  mice subjected to a 24-h fast.
(B) Oil red O staining of histologic sections of liver taken from PGC-1a
 /  mice under fed and 24 h fasted conditions. The red staining indicates
neutral lipid.
(C) Representative electron micrographs of the liver from PGC-1a
þ/þ and PGC-1a
 /  mice following a 24-h fast. The droplets are indicative of
neutral lipid accumulation.
(D) Mean liver TAG levels in PGC-1a
þ/þ (n = 5) and PGC-1a
 /  (n = 5) mice under fed and 24-h fasted conditions. * p , 0.05.
DOI: 10.1371/journal.pbio.0030101.g007
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Metabolic Derangements in PGC-1a DeficiencyGlucose tolerance testing in 4.5-mo-old female PGC-1a
 / 
mice revealed that, despite increased body weight [mean 6
standard error of the mean (SEM) weight of PGC-1a
þ/þ mice
= 22.4 6 0.79 g; PGC-1a
 /  mice = 25.2 6 1.04 g), PGC-1a
 / 
mice exhibited similar levels of glucose tolerance compared
to WT mice on standard rodent chow (Figure 9). To examine
glucose homeostasis in response to high-fat diet, female
PGC-1a
þ/þ and PGC-1a
 /  mice were placed on high-fat chow
(43% calories from fat) for 6 wk starting at 8 wk of age. The
weight gained on the high-fat diet was similar for the PGC-
1a
þ/þ and PGC-1a
 /  groups (Figure S3). Surprisingly, the
PGC-1a
 /  mice on a high-fat diet were signiﬁcantly more
glucose-tolerant and insulin-sensitive compared to the PGC-
1a
þ/þ mice (Figure 9B). Taken together, these results indicate
that, despite excess body fat under standard conditions, the
female PGC-1a
 /  mice do not exhibit insulin resistance.
Moreover, the PGC-1a
 /  mice are more glucose-tolerant
and insulin-sensitive than WT mice on a high-fat diet.
Structural Abnormalities of the Central Nervous System in
PGC-1a
 /  Mice
In surveying the tissues of the PGC-1a
 /  mice, structural
abnormalities of the brain were observed. Light microscopic
examination of PGC-1a
 /  brain tissue samples demonstrated
a well-preserved cerebral cortical neuronal complement, a
result conﬁrmed by measurement of neuron density in
sections of the parietal lobe (PGC-1a
þ/þ,1 , 2 6 16 91
neurons/mm
2 versus PGC-1a
 / , 1,299 6 82 neurons/mm
2;
not signiﬁcant). Patchy areas of microvacuolation involving
the neuropil and individual pyramidal neurons of the deep
layers of the cerebral cortex were noted in the PGC-1a
 / 
mice but not the PGC-1a
þ/þ mice (Figure 10A). Immunoloc-
alization of an astrocytic marker, glial ﬁbrillary acidic
protein, failed to show an increase in numbers of astrocytic
processes in PGC-1a
 /  mouse cerebral cortex (unpublished
data). The hippocampus also showed neuronal microvacuo-
lation, albeit to a lesser degree than the parietal cortex.
Microvacuolation of the neuropil and neurons of the PGC-
1a
 /  basal ganglia (caudate and putamen) was also noted in
association with a patchy increase in the number and
intensity of glial ﬁbrillary acidic protein-immunoreactive
astrocytic processes (unpublished data). Areas of micro-
vacuolation also involved multiple brainstem regions. Only
rare vacuolated Purkinje and granule cell neurons were
identiﬁed in the PGC-1a
 /  cerebellar cortex. Neither micro-
glial proliferation nor perivascular lymphocytic inﬂammatory
inﬁltrates were noted in the PGC-1a
 /  CNS.
Ultrastructural examination of the PGC-1a
 /  parietal
cerebral cortex conﬁrmed the presence of microvacuolated
neurons and neuropil (Figure 10B). Vacuoles containing
aggregates of membranous material were present in a subset
of cortical neurons. Subcellular localization of the vacuoles
was difﬁcult to establish; some may represent vacuolated
elements of the neuropil, material in phagocytic cells,
presynaptic nerve terminals compressing the soma, or
genuine intraperikaryal deposits.
Figure 8. Hepatocytes Isolated from PGC-1a
 /  Mice Exhibit Reduced Oxidative Capacity
(A) Oil red O staining of isolated hepatocytes exposed to BSA alone (BSA) or 50 lM oleate complexed to BSA (oleate).
(B)
3H-palmitate oxidation rates.
3H-palmitate oxidation rates determined in hepatocytes isolated from PGC-1a
þ/þ and PGC-1a
 /  mice under
cell culture conditions containing BSA or BSA þ 50 lM oleate (2:1 oleate/BSA ratio). Values were derived from ten sets of triplicates for each
group using hepatocytes from 5 mice of each genotype. The bars represent mean oxidation rates (n = 100) normalized to the condition of PGC-
1a
þ/þ in BSA alone. * p , 0.05 compared to the corresponding PGC-1a
þ/þ mice.
 p , 0.05 compared to PGC-1a
þ/þ with BSA treatment.
(C) State 2 and 3 respiration rates determined for hepatocytes isolated from PGC-1a
þ/þ (n = 3) and PGC-1a
 /  (n = 3) mice using succinate/
rotenone as a substrate. * p , 0.05 compared to corresponding PGC-1a
þ/þ.
(D) TAG synthesis rates in isolated hepatocytes. The bars represent mean TAG synthesis rates (glycerol incorporation, see Materials and Methods)
for hepatocytes isolated from PGC-1a
þ/þ(n = 6) and PGC-1a
 / (n = 6) mice. * p , 0.05 compared to the corresponding PGC-1a
þ/þcondition.
DOI: 10.1371/journal.pbio.0030101.g008
PLoS Biology | www.plosbiology.org April 2005 | Volume 3 | Issue 4 | e101 0680
Metabolic Derangements in PGC-1a DeficiencyDiscussion
Previous studies using gain-of-function strategies have
shown that the coactivator PGC-1a is capable of coactivating
an array of transcription factors involved in energy metabolic
processes including fatty acid oxidation, electron transport,
and oxidative phosphorylation [6]. Forced expression of PGC-
1a triggers mitochondrial biogenesis by activating a complex
circuitry of factors including NRF-1, NRF-2, and the orphan
nuclear receptor estrogen-related receptor a [23,32]. How-
ever, gain-of-function strategies cannot determine whether
PGC-1a is essential for critical energy metabolic processes
including mitochondrial biogenesis and function. Using
targeted gene deletion in mice, we show here that PGC-1a
is not essential for normal embryologic development or the
fundamental events of mitochondrial biogenesis. However,
several lines of evidence support the conclusion that PGC-1a
is necessary for the programs that regulate postnatal
mitochondrial function and cellular energy metabolism,
processes that equip the organism for the energy metabolic
rigors of the postnatal environment. First, mitochondrial
volume density is diminished in slow-twitch skeletal muscle of
PGC-1a
 /  mice. Second, mitochondrial respiratory capacity
is modestly but signiﬁcantly altered in skeletal muscle and
liver of PGC-1a
 / mice. Third, the growth of heart and soleus
muscle, tissues with high reliance on mitochondrial energy
production, is blunted. Fourth, control of body fat mass is
abnormal in the PGC-1a
 /  mice. Finally, PGC-1a
 /  mice do
not respond normally to a variety of physiologic and dietary
stresses known to increase oxidative energy demands. Taken
together, these results strongly suggest that PGC-1a is
necessary for the terminal stages of mitochondrial matura-
Figure 9. Female PGC-1a
 /  Mice Are More Glucose Tolerant and Insulin
Sensitive Compared to PGC-1a
þ/þ on High-Fat Diet
(A) At 4.5 mo of age, glucose tolerance testing (GTT) was performed
on female PGC-1a
þ/þ (n = 6) and PGC-1a
 /  (n = 6) mice maintained
on standard chow.
(B) At 8 wk of age, PGC-1a
þ/þ (n = 8) and PGC-1a
 /  (n = 11) mice
were provided a diet containing 43% of its calories from fat (HF
chow). The graphs depict blood glucose levels 6 SEM in PGC-1a
 / 
mice during GTT (left graph) and ITT (right graph) studies. Studies
were performed 5 wk (GTT) and 6 wk (ITT) after the initiation of the
high-fat diet. * p , 0.05 compared to PGC-1a
þ/þmice at the same time
point.
DOI: 10.1371/journal.pbio.0030101.g009
Figure 10. Neuropathology of the Central Nervous System of PGC-1a
 /  Mice
(A) Light microscopic appearance of representative cerebral cortex of 2-mo-old PGC-1a
 /  mice demonstrates marked vacuolation of the
neuropil (arrows) and scattered neuronal perikarya, which are absent in PGC-1a
þ/þ mice (hematoxylin and eosin). The scale bar shown is
applicable to all sections.
(B) Ultrastructural appearance of typical vacuoles containing membranous debris, denoted by the arrow, in the cerebral cortex of a
representative PGC-1a
 /  mouse in comparison to PGC-1a
þ/þ (magniﬁcation 40003).
DOI: 10.1371/journal.pbio.0030101.g010
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environment.
Extensive phenotypic analyses demonstrated that mice
lacking PGC-1a are unable to cope with physiologic stressors
relevant to postnatal survival. For example, a skeletal muscle
phenotype was unveiled in PGC-1a
 /  mice under conditions
in which energy supply becomes limiting. This was most
clearly demonstrated by the profound abnormalities ex-
hibited by PGC-1a
 /  mice with exercise-to-exhaustion and
repetitive muscle stimulation studies. Similarly, cardiac
performance of PGC-1a
 /  mice was compromised following
severe exertion. This effect was largely due to an abnormal
heart rate response. The basis for the observed abnormalities
of cardiac heart rate, including a blunted response to b-
adrenergic stimulation, is unknown, but could be related to
the effects of late-stage growth arrest and corresponding
derangements in energy metabolism on sinus node function.
PGC-1a was ﬁrst identiﬁed as a coactivator in BAT [2].
Indeed, we found that exposure of the PGC-1a
 /  mice to
cold, another relevant physiologic stress, resulted in an
untoward drop in core body temperature consistent with an
abnormality in thermogenesis despite normal cold induction
of UCP-1 mRNA in BAT. Studies with a b3-adrenergic agonist
conﬁrmed that the peak oxygen consumption rate in
thermogenic tissue is diminished in PGC-1a
 /  mice. We
propose that the thermogenic phenotype is related to
reduced capacity for mitochondrial respiration in BAT.
Interestingly, this phenotype was only evident during a rather
narrow window of postnatal life. Animals at an older age did
not exhibit cold intolerance, possibly due to the insulating
properties of increased body mass. Collectively, these results
demonstrate the importance of PGC-1a as a key transducer of
physiologic stimuli to the control of energy metabolism.
The observation of fasting-induced hepatic steatosis is
another example of the inability of PGC-1a
 / mice to respond
to postnatal environmental metabolic demands. Following
short-term starvation, we found that the PGC-1a
 /  mice
developed marked hepatocyte triglyceride accumulation.
Further analysis revealed that palmitate oxidation rates were
reduced in hepatocytes isolated from the PGC-1a
 /  mice,
which would predispose to lipid accumulation. Surprisingly,
the reduction in fatty acid oxidation rates in PGC-1a null
hepatocytes was not due to altered expression of PGC-1a/
PPAR target genes involved in mitochondrial fatty acid
oxidation. However, mitochondrial respiratory rates were
diminished. In addition, we found that triglyceride synthesis
was abnormally activated, and the expression of genes
encoding SREBP-1c and SCD-1, key proteins in the hepatic
lipogenic pathway, failed to be appropriately down-regulated
in fasted PGC-1a
 /  mice. The mechanism involved in this
latter ﬁnding is unknown. Indeed, the relative contribution of
increased triglyceride synthesis rates to the steatotic pheno-
type cannot be fully discerned from our data, given that this
response could reﬂect the direct effects of PGC-1a deﬁciency
on target genes or a secondary compensatory response to
hepatocyte fatty acid accumulation. Consistent with the
former possibility, recent evidence indicates that PGC-1a
coactivates the nuclear receptor FXR, a negative regulator of
SREBP-1c expression and triglyceride synthesis [33]. We
conclude that reduced hepatocyte mitochondrial respiratory
capacity, and possibly activation of lipogenic programs, result
in hepatocyte triglyceride accumulation in the context of
increased hepatic delivery of fatty acids such as occurs with
fasting.
We found that after 18 wk of age, female PGC-1a
 /  mice
exhibit a mild but signiﬁcantly abnormal weight increase
associated with increased fat stores. Lean mass was un-
changed at the time points examined. With further aging, a
modest but signiﬁcant increase in body fat was also noted in
male PGC-1a
 /  mice (unpublished data). The basis for the
observed abnormalities in weight control is unknown. We did
not ﬁnd differences in food intake or activity levels in female
PGC-1a
 /  mice. It is possible that a reduction in systemic
energy utilization, related to the mitochondrial dysfunction,
leads to increased fat mass and weight gain in the PGC-1a
 / 
mice. Interestingly, an association between PGC-1a gene
polymorphisms and obesity in humans has been recently
reported [26]. Clearly, future studies of male and female PGC-
1a
 /  mice in pure-strain backgrounds over a range of ages
will be necessary to fully investigate the observed abnormal-
ities in weight control and fat distribution.
We did not ﬁnd evidence for glucose intolerance or insulin
resistance in the PGC-1a
 /  animals on standard chow. More-
over, female PGC-1a
 /  mice were more glucose-tolerant and
insulin-sensitive than PGC-1a
þ/þ controls when consuming a
high-fat diet. These ﬁndings are surprising, given the results of
several recent studies demonstrating reduced expression of
PGC-1a in human diabetic skeletal muscle [24,34]. It is
certainly possible that compensatory metabolic regulatory
mechanismshavebeenactivatedinthePGC-1a-deﬁcientmice,
accounting for this observation. Alternatively, PGC-1a could
serve as a coactivator of factors that mediate diet-induced
insulin resistance. Consistent with this notion, we and others
have shown that mice lacking the PGC-1a target PPAR exhibit
resistance to diet-induced glucose intolerance [21,35,36].
Histologic surveys of the PGC-1a
 /  mice revealed ultra-
structural abnormalities in the central nervous system.
Inspection of sections prepared from the brains of PGC-
1a
 /  mice revealed patchy areas of microvacuolation in the
pyramidal neurons of the cerebral cortex, accompanied by a
mild increase in the number of astrocytes in the basal ganglia.
The basis for this interesting but relatively nonspeciﬁc
ﬁnding is unknown. It is possible that PGC-1a plays an
important role in lipid metabolism related to membrane
synthesis. Alternatively, the normal process of cellular debris
turnover could be altered due to a defect in the energetics of
the microglial component of the central nervous system.
Although overt neurologic dysfunction was not apparent in
PGC-1a
 /  mice during the ﬁrst 6 mo of life (no group
differences were found on ﬁve of six sensorimotor tests), the
PGC-1a
 /  mice showed clear deﬁcits on the inverted screen
test. These deﬁcits are likely due to impaired muscle strength
in the PGC-1a
 /  mice, but contributions by peripheral or
central nervous system determinants (or both) could be
contributory. Moreover, evidence of altered emotionality
from the 1-h locomotor activity test also suggests the
possibility of altered brain function in PGC-1a
 /  mice. It
will be of interest to determine whether the neurologic
abnormalities contribute to the systemic metabolic abnor-
malities of the PGC-1a null mice.
During the preparation of this manuscript, Lin et al.
reported an independent mouse line in which the PGC-1a
gene was targeted [37]. Phenotypic comparison of the our
PGC-1a-deﬁcient line with that of Lin et al. reveals a number
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1a-deﬁcient lines exhibit cold intolerance, reduced hepato-
cyte respiration rates, and neurologic lesions. However, a
number of interesting differences are notable. First, in
contrast to Lin et al., the PGC-1a
 /  mice described here do
not exhibit any postnatal mortality. Second, we did not ﬁnd
evidence for a defect in gluconeogenesis based on fasting
blood glucose levels (unpublished data). In addition, whereas
Lin et al. found an abnormal expression proﬁle for CCAAT-
enhancer-binding protein b and d and the gluconeogenic
genes encoding phosphoenolpyruvate carboxykinase and
glucose-6-phosphatase at baseline and with fasting in the
PGC-1a
 /  mice, we did not (unpublished data). Third, we
found evidence for an age-related increase in body fat in
PGC-1a
 /  mice (females earlier than males), whereas Lin et
al. identiﬁed a male-speciﬁc resistance to diet-induced
obesity and insulin resistance. We have also found that male
PGC-1a-deﬁcient mice are somewhat protected against diet-
induced obesity (Figure S4). However, we observed that the
insulin-sensitive phenotype of the female PGC-1a
 /  mice
occurred in the context of normal weight gain with high-fat
diet. These latter results indicate that the insulin-sensitive
phenotype of PGC-1a
 /  mice cannot be fully explained by a
lean phenotype. Of interest, mice lacking the nuclear
receptor estrogen-related receptor a, a known target of
PGC-1a, exhibit resistance to diet-induced obesity similar to
that of male PGC-1a null mice [38]. Fourth, the PGC-1a
 / 
mice described here exhibit a dramatic fasting-induced
hepatic steatotic phenotype, whereas the Lin et al. mouse
does not. Fifth, Lin et al. found a neurologic phenotype in
males characterized by hyperactivity, whereas the PGC-1a
 / 
mice described here show reduced locomotor activity.
However, it should be noted that we did not study activity
levels over an extended period of time in males as did Lin et
al., so it is possible that our ﬁndings reﬂect an emotional
disturbance that manifests only when the animals are placed
in a new environment. Finally, we report signiﬁcant skeletal
muscle and cardiac functional abnormalities (although the
report by Lin et al. did not address these phenotypes, so this
may not represent a true difference).
The reasons for the interesting differences between the two
PGC-1a-deﬁcient mouse lines are not clear. It is possible that
distinct genetic backgrounds related to hybrid strains confer
different degrees of secondary compensatory responses. In
addition, the incompletely penetrant postnatal mortality
noted in the PGC-1a
 /  mice reported by Lin et al. could
have resulted in a selection bias toward greater levels of
compensatory responses in liver and other tissues in the
surviving group. It is also possible that the method of gene
targeting led to different phenotypes. Lin et al. generated
PGC-1a
 /  mice by Cre recombinase-mediated excision of
exons 3–5 in oocytes. The PGC-1a
 /  mice described here
were generated by a targeting event that involved a 39
homologous recombination leading to an insertion of the
targeting vector including an extra exon 3 between exons 5
and 6. The exon 3 insertion, which was conﬁrmed by RT-PCR,
results in a mutant transcript that encodes a truncated
protein. We were unable to detect normal transcript
containing an exon 5–6 border, indicating that the targeting
was accurate and complete. In addition, we could not detect
full-length or smaller PGC-1a proteins by Western blotting.
However, we cannot exclude the possibility that the sensi-
tivity of the immunoblotting was not high enough to pick up
a small amount of mutant (truncated) PGC-1a protein that
could have some activity, given that it would contain nuclear
receptor-interacting domains and the amino-terminal acti-
vation domain. If small amounts of PGC-1a activity are
present in the mice reported here, it could explain some of
the observed differences between the models. However, the
bulk of data presented here support the conclusion that the
PGC-1a
 /  mice described are completely deﬁcient in PGC-
1a. Future direct comparison of the two mouse lines in pure
background strains will be of interest.
In summary, this body of work provides evidence that PGC-
la is critical for the adaptive responses necessary to meet
postnatal energy demands. Our results also suggest a broader
role for inducible transcriptional coactivators such as PGC-1a
in transducing cellular signals triggered by physiologic and
developmental cues to the transcriptional control of energy
metabolism and other dynamic cellular processes. In this
regard, the inducible coactivator PGC-1a serves as a tran-
scriptional ‘‘booster’’ to augment the capacity of downstream
metabolic pathways critical for metabolic maturation and
postnatal growth. Indeed, although PGC-1a null mice survive
in the protected environment of the laboratory, our results
indicate that in the rigors of a typical external environment,
PGC-1a would be necessary for survival. Lastly, we propose
that the PGC-1a
 /  mice should serve as a useful murine
model to investigate the role of altered energy metabolism in
obesity, diabetes, hepatic steatosis, and diseases of the heart,
skeletal muscle, and central nervous system.
Materials and Methods
Targeting the PGC-1a gene in mice. A BAC genomic clone
containing the murine PGC-1a gene, isolated from an Sv129 genomic
library, was obtained from Incyte Genomics (Palo Alto, California,
United States). A 3-kb region spanning exon 3 was ampliﬁed from the
genomic clone. A 59 primer was designed to amplify a fragment with
the 59 end beginning 732 bp upstream of exon 3 just upstream of an
endogenous Kpn1 restriction site (59-AGTTTCCTTAGCAACTTCA-
TA-39). The 39 primer contained a BamH1 site engineered by
mutating the bases shown in lowercase (59-AAGGATTTTAgGATcc-
CAGTAC-39). A second fragment downstream of exon 5 was
ampliﬁed. In this latter amplicon, Not1 and Xho1 sites were
engineered into the 59 and 39 primers, respectively (59-
TGGAGTgcGGCCGCTGGGA-39 and 59-AAAGAGTCTCgAgAA-
TAGTTTCT-39). The fragments were cloned into p1339-PGK-Neo-
mycin targeting vector. The construct was linearized with Xho1 and
electroporated into RW4 ES cells (Sv129 derived) using G418
selection. The electroporation was performed by the Siteman Cancer
Center ES Cell Core at Washington University (St. Louis, Missouri,
United States). The clones were screened by Southern blot using an
Xba1 digest (see Figure 1A and 1B). One clone out of approximately
400 screened was positive for the homologous recombination on the
39 end and an insertion on the 59 end. This clone was injected into a
C57BL6/J blastocyst. Chimeras were mated to C57BL6/J mice and
germline transmission was conﬁrmed by Southern blotting of tail
DNA (see Figure 1B). All experiments were performed using sex- and
age-matched or littermate controls as noted.
General animal studies. All animal experiments and euthanasia
protocols were conducted in strict accordance with the National
Institutes of Health guidelines for humane treatment of animals and
were reviewed and approved by the Animal Care Committee of
Washington University.
Animals were weighed at different time points. Male and female 3-
to 8-wk-old PGC-1a
þ/þ and PGC-1a
 /  mice were euthanized, and
tissues were dissected and weighed on an analytical balance. Tissue
weights were corrected for total body weight before comparison.
DEXA studies were performed as previously described [39] using a
Lunar PIXIMUS DEXA system at 10, 18, and 24 wk in male and female
PGC-1a
þ/þ and PGC-1a
 /  mice. For cold exposure experiments, male
and female PGC-1a
þ/þ and PGC-1a
 /  mice were singly housed and
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monitored by rectal probe at baseline and every hour thereafter.
Mice were monitored at least every 30 min to check for lethargy. At
the end of 5 h, mice were sacriﬁced and tissues harvested for RNA
and protein extraction. For fasting studies, animals were singly
housed and given water ad libitum. Food was removed from cages in
the morning and tissues harvested at 24 h for RNA and histology.
Photography of the mice was performed by MedPic at Washington
University School of Medicine. 48-h activity monitoring was
performed by JAX Services (The Jackson Laboratory, West Sacra-
mento, California, United States) using a Comprehensive Laboratory
Animal Monitoring System (CLAMS, Columbus Instruments, Colum-
bus, Ohio, United States). Brieﬂy, 3-mo-old female mice were
acclimated for 17 h before data collection. Data were collected every
30 min. Total beam breaks in the XY direction were tabulated for the
12-h light and dark cycles and compared across genotypes.
RNA, DNA, and protein analyses. Total RNA was isolated by the
RNAzol method (Tel-Test, Friendswood, Texas) and Northern
blotting was performed as previously described [40]. The PGC-1b
and PRC cDNAs were generous gifts from Bruce Spiegelman and
Richard Scarpulla, respectively. The UCP-1 cDNA was a gift from
Daniel Ricquier. RT-PCR was performed as described [41]. In brief,
total RNA isolated from soleus muscle, BAT, and heart of 1–2-mo-old
PGC-1a
þ/þ or PGCa
 /  mice was reverse transcribed with Taqman
reverse transcription reagents (Applied Biosystems, Foster City,
California, United States). Reactions were performed in triplicate
in 96-well format using Taqman core reagents and a Prism 7500
Sequence Detector (Applied Biosystems). The mouse-speciﬁc primer-
probe sets used to detect speciﬁc gene expression can be found in
Table S1. The primers for UCP-1 have been previously described [42].
Actin primer-probe set (Applied Biosystems) was included in a
separate well and used to normalize the soleus, BAT, and heart gene
expression data. GAPDH Rodent primers (Applied Biosystems) were
used in the same well to normalize the liver gene expression data.
For Southern blot studies, 5 lg of genomic DNA was digested with
Pst1 or Xba1, electrophoresed on a 0.8% TAE gel and transferred to a
Gene Screen (Perkin Elmer, Wellesley, California, United States)
membrane for hybridization. Western blotting was performed as
described [43] using the Enhanced Chemiluminescence detection
system (Amersham Pharmacia Biotech, Piscataway, New Jersey,
United States). Ponceau S (Sigma, St. Louis, Missouri, United States)
staining of the membrane was used as a control.
Mitochondrial respiration studies. Mitochondrial respiration was
assessed in saponin-skinned soleus ﬁbers with succinate as substrate
and in the presence of rotenone as previously described [44]. In
brief, 3-mo-old female mice were anesthetized with chloral hydrate
(400 mg/kg of body weight). Soleus ﬁbers were separated and then
transferred to a buffer (2.77 mM K2Ca-EGTA, 7.23 mM K2EGTA,
6.56 mM MgCl2, 20 mM imidazole, 53.3 mM K-MES, 20 mM taurine,
5.3 mM ATP, 15 mM PCr, 3 mM KH2PO4, 0.5 mM DTT [pH 7.1])
supplemented with 50 lg/ml saponin and permeabilized for 30 min
at 4 8C with gentle stirring. Fibers were then washed twice for 10 min
each (2.77 mM K2Ca-EGTA, 7.23 mM K2EGTA, 1.38 mM MgCl2,
20 mM imidazole, 100 mM K-MES, 20 mM taurine, 3 mM KH2PO4,
0.5 mM DTT, 2 mg/ml BSA [pH 7.1]). Respiration was measured at
25 8C using an optical probe (Oxygen FOXY Probe, Ocean Optics,
Dunedin, Florida, United States). Following measurement of basal
state 2 respiration, maximal (ADP-stimulated) state 3 respiration was
determined by exposing ﬁbers to 1 mM ADP. The integrity of the
outer mitochondrial membrane was assessed by adding 8 lM
exogenous cytochrome c to ADP-stimulated ﬁbers. State 4 respira-
tion (uncoupled) was evaluated following addition of oligomycin
(1 lg/ml). The solubility of oxygen in the respiration buffer at 25 8C
was taken as 246.87 nmol O2   ml
 1. Respiration rates were expressed
as nmol O2   min
 1   mgdw
 1.
Insulin and glucose tolerance tests. Glucose and Insulin tolerance
tests were performed as described [35]. Prior to studies, mice were
fasted overnight (GTT) or 6 h (ITT). In GTT studies, mice were
injected with a 10% solution of D-glucose (1 g/kg). For ITT, mice
received an IP injection of human regular insulin (Eli Lilly, Indian-
apolis, Indiana, United States) at a dose of 0.75 units/kg of body
weight. Tail blood glucose was determined at 0, 30, 60, and 120 min
after challenge using a B-GLUCOSE Analyzer (Hemacue AB,
Angelholm, Sweden).
Indirect calorimetry. Oxygen consumption rates (VO2) of 5-wk-old
female mice were measured using a Columbus Instruments Oxymax
System.Restingbaselineoxygenconsumptionrateswereassessedforat
least 1.0 h. For b3-adrenergic stimulation studies, BRL 37344 (Sigma)
wasdissolvedinsterilesalineandinjectedIP(2lg/gofbodyweight)[45].
Postagonist assessment of oxygen consumption was recorded for an
additional 1.0 h, with data collected at the 40-min time point.
Histology and electron microscopy. Soleus muscle and liver were
dissected and ﬁxed overnight in 2% glutaraldehyde, 1% paraformal-
dehyde, and 0.08% sodium cacodylate buffer. The tissues were
postﬁxed in 1% osmium tetroxide, dehydrated in graded ethanol,
embedded in Poly Bed plastic resin, and sectioned for electron
microscopy. Cardiac and skeletal muscle mitochondrial and myoﬁ-
brillar volume densities were determined from electron micrographs
as described previously [10]. For each animal, three different ﬁelds at
the magniﬁcation of 75003 were quantiﬁed in blinded fashion. Data
were expressed as mean volume density of mitochondria or
myoﬁbrils in each ﬁeld.
For electron microscopic analysis of the brain, tissue was prepared
as previously described [46]. Ultrathin sections of cortex were cut
onto formvar-coated slot grids stained with uranyl acetate and lead
citrate and examined with a JEOL 1200 electron microscope. For
H&E staining, sections of brain, including cerebral cortex, brainstem,
and cerebellum, were dehydrated in graded concentrations of alcohol
and embedded in parafﬁn from which 5-lm sections were prepared.
Primary mouse hepatocyte studies. Primary cultures of mouse
hepatocytes were prepared from male PGC-1a
þ/þ and PGC-1a
 / 
mice essentially as described [47]. Fatty acid oxidation and
triglyceride synthesis experiments were commenced 2–3 h after
the cells were plated. Triglyceride synthesis studies, were performed
as previously described [47]. Palmitate oxidation rates were
quantiﬁed using [9,10-
3H]-palmitic acid as described [48] and
corrected for total cellular protein content. For respiration studies,
cells were spun down prior to plating and resuspended in a
permeabilization buffer (described above) containing 50 lg/ml
saponin. Respiration studies were performed in the presence of 5
mM succinate in the presence of 10 lM rotenone. Respiration rates
were expressed as nmol O2   min
 1   mg of protein
 1.
Evaluation of locomotor activity, sensorimotor capabilities, and
muscle function. To evaluate general activity levels and muscle use,
micewereevaluatedovera1-hperiodintransparent(47.6cm325.4cm
320.6 cm) polystyrene enclosures as previously described [49] using a
high-resolutionphotobeamsystem(MotorMonitor,Hamilton-Kinder,
Poway, California, United States). Each enclosure was surrounded by a
framecontaining a 438 matrixof photocellpairs, theoutput of which
was fed to an on-line computer. The system software (Hamilton-
Kinder) was used to deﬁne a 33 cm 3 11 cm central zone and a
peripheral or surrounding zone that was 5.5 cm wide with the sides of
thecagebeingtheoutermostboundary.Thisperipheralareaextended
along the entire perimeter of the cage. Variables that were analyzed
included the total number of ambulations, as well as the number of
entries, the time spent, and the distance traveled in the center area as
well as the distance traveled in the periphery surrounding the center.
The total number of ambulations and rearings were recorded. For the
inverted screen test, mice were placed on a wire mesh grid (16 squares
per10cm)andthescreenwasinvertedto1808.Amaximumscoreof60s
was given if an animal did not fall.
The tests included in the sensorimotor battery [50] and accom-
panying protocols were designed as follows. (1) Inclined screen and
inverted screen tests: For the inclined screen tests, each mouse was
placed on top of an elevated (47 cm above the ﬂoor) wire mesh grid
(16 squares per 10 cm) that was inclined to 608 or 908. Each animal
was placed in the middle of the screen with its head oriented down
and was timed for how long it remained on the screen and how long it
took to climb to the top of the screen. For the inverted screen test,
mice were placed as above and then the screen was inverted to 1808.A
maximum score of 60 s was given if an animal did not fall; (2)
Platform test: Each mouse was timed for how long it remained on an
elevated (47 cm above the ﬂoor) circular platform (1.0 cm thick and
3.0 cm in diameter). A maximum score of 60 s was assigned if the
mouse remained on the platform for the maximum amount of time
or if it could climb down on a very thin pole that supported the
platform, without falling; (3) Ledge test: Each mouse was timed for
how long it could maintain its balance on a 0.75-cm wide Plexiglas
ledge without falling (60 s maximum). A score of 60 s was also
assigned if the mouse traversed the entire length (51 cm) of the
Plexiglas ledge and returned to the starting place in less than 60 s
without falling; (4) Walking initiation test: Each mouse was placed in
the middle of a square outlined by white cloth tape (21 cm 3 21 cm)
on a smooth black surface of a large tabletop. The time it took each
mouse to leave the square (place all four paws outside of the tape) was
recorded. The maximum time allowed was 60 s.
6–8-mo-old PGC-1a
þ/þ (n = 4) and PGC-1a
 /  (n = 8) mice were
run to exhaustion employing a motorized, speed controlled, modular
treadmill system (Columbus Instruments). The treadmill was equip-
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angle. Running velocity was set at 35 m/min, with a level inclination
angle.
VO2max studies. VO2max was determined while the mice were
running on a treadmill using an open ﬂow system (Columbus
Instruments Oxymax System). All measurements of oxygen con-
sumption took place at an elevation of 150 m (ambient PBAR = 745
torr). Animals were placed into the metabolic chamber for 3–5 min to
allow the system to equilibrate. Mice were then induced to run up an
188 incline at a speed of 40 m/min using a shock grid in the rear of the
chamber. The speed was increased by 5 m/min every 2 min until the
animals were unable to continue. Maximal effort was determined
when oxygen uptake did not increase with power output and
subsequently the mouse failed to maintain effort. VO2max was
calculated using the averaged values over 1 min during which the
animal’s O2 consumption reached a plateau.
Isolated muscle stimulation studies. Animals were anesthetized
with ketamine/xylazine and the soleus muscle was removed from one
leg. Upon removal, the muscle was suspended in a Krebs solution
aerated with 95% O2 and 5% CO2. The muscle and Krebs solution
were suspended within a water bath maintained at 37 8C, and the
muscle was anchored to a Grass (West Warwick, Rhode Island, United
States) isometric force transducer (model FTO3C). Muscles were
stimulated to contract with a Grass stimulator (model S88) generating
a ﬁeld stimulus through electrodes located at both ends of the muscle.
Force-voltage (maximal force at about 100 V) and length-tension
relationships were determined using single twitch stimuli. The
stimulator then delivered repeating trains of stimuli at one per
second at 40 Hz for 2 min. Each train lasted 330 ms, and were digitally
recorded using MacLab (AD Instruments, Colorado Springs, Colo-
rado, United States). Fatigue resistance was calculated as the ratio of
the force generated by the last tetanus divided by the highest force
generated multiplied by 100 to give the percent of force generation
that remained after the fatigue protocol.
Exercise echocardiography. Adult female mice (6–8 mo old) were
exercised on the motorized treadmill using the run-to-exhaustion
settings described above for 60 s or until exhaustion, whichever came
ﬁrst. Immediately following its treadmill run, the mouse was
subjected to serial echocardiography using an Acuson Sequoia
Echocardiography System performed as previously described [51].
In vivo cardiac hemodynamic studies. Hemodynamic studies were
performed as previously described with some modiﬁcations [52]. In
brief, adult mice (10–12 wk) were anesthetized intraperitoneally (IP)
with thiopental sodium (60 mg/kg). The mice were intubated and ven-
tilated with a Harvard ventilator. The right carotid artery was isolated
in the region of the trachea and cannulated with a 1.4-French high-
ﬁdelitymicromanometercatheter(MillarInstruments,Houston,Texas,
United States), which was inserted into the left ventricle retrograde
acrosstheaortic valve. Hemodynamic measurements were recordedat
baselineand3minfollowingcontinuousinfusionofincrementaldoses
of dobutamine (b1, b2, and a1-adrenergic agonist) up to 32 ng  
gBW
 1  min
 1 [53]. Continuous pressure-volume data were acquired
and digitized with the BioBench computer software data acquisition
system (National Instruments, Austin, Texas, United States).
Isolated working mouse heart perfusion. Isolated working mouse
heart perfusion was based on a previously described procedure [54].
Adultmice(4–7moold)wereheparinized(100unitsIP)10minpriorto
anesthesia. Animals were then deeply anesthetized with 5–10 mg of
sodiumpentobarbitalIP.Heartswereexcisedandplacedinanice-cold
Krebs-Henseleit bicarbonate (KHB) solution [118 mM NaCl, 25 mM
NaHCO3,4.7mMKCl,1.2mMKH2PO4,2.5mMCaCl2,5.0mMglucose,
and 100 units/L insulin (pH 7.4)]. Hearts were cannulated ﬁrst via the
aortaandperfusedretrogradelybytheLangendorffmethod.Following
left atrial cannulation, perfusion was switched to the working mode
with KHB solution containing 1.2 mM palmitate bound to 3% fatty
acid-free BSA with a preload pressure of 11.5 mm Hg and an afterload
pressure of 50 mm Hg for 60 min with oxygenated buffer solution.
Functional measurements, namely cardiac output, aortic ﬂows, peak
systolic pressure, and heart rate were acquired every 10 min using
inline ﬂow probes (Transonic Systems, Ithaca, New York, United
States), a pressure transducer (TSD 104A, BIOPAC Systems, Santa
Barbara, California, United States) and data acquired with the MP100
system from AcqKnowledge (BIOPAC Systems). Cardiac work was
calculated as the product of peak systolic pressure and cardiac output.
Statistics. Data were analyzed using T-tests or ANOVAs (measures
of general activity and sensorimotor battery). The level of signiﬁcance
was set at p , 0.05 in all cases. Data are reported as mean values 6
SEM, unless otherwise noted. The ANOVA model used to analyze
each sensorimotor test included one between-subjects variable
(genotype), and one within-subjects variable (trials). When ANOVAs
with repeated measures were conducted, the Huynh-Feldt (H-F)
adjustment of alpha levels was used for all within-subjects effects
containing more than two levels, in order to protect against
violations of the sphericity/compound symmetry assumptions under-
lying this ANOVA model. In addition, Bonferroni correction was
used when appropriate to help maintain prescribed alpha levels
(e.g., p , 0.05) when multiple comparisons were conducted.
Supporting Information
Figure S1. Activity Levels in Female PGC-1a
 /  Mice Is Unchanged
Using a CLAMS system, PGC-1a
þ/þ (n = 4) and PGC-1a
 /  (n =3 )
female mice were monitored for 48 h after a 17-h period of
acclimation. XY beam breaks were tabulated over the 12-h light and
dark cycles as denoted on the bottom. The bars represent mean
(6 SEM) beam breaks per each 12-h cycle.
Found at DOI: 10.1371/journal.pbio.0030101.sg001 (342 KB EPS).
Figure S2. Altered Emotionality in PGC-1a
 /  Mice
An analysis of exploratory behavior included the number of entries
into the center of the cage (upper left), the time spent in the center of
the cage in seconds (sec) (upper right), the distance traveled in the
center of the cage in meters (m) (lower left) as well as the distance
traveled in the periphery (lower right). * p , 0.05 compared to the
PGC-1a
þ/þ mice.
Found at DOI: 10.1371/journal.pbio.0030101.sg002 (620 KB EPS).
Figure S3. No Difference in Weight Gain on a High-Fat Diet in
Female PGC-1a
 /  Mice Compared to WT Controls
8-wk-old female mice were fed a diet high in fat (43% calories from
fat) for 6 wk. The change in body weight (grams) after 6 wk on a high-
fat diet is shown for PGC-1a
þ/þ (n = 8) and PGC-1a
 /  (n = 11) mice.
NS, not signiﬁcant.
Found at DOI: 10.1371/journal.pbio.0030101.sg003 (264 KB EPS).
Figure S4. Male PGC-1a
 /  Mice Are Somewhat Resistant to Diet-
Induced Obesity
Male and female PGC-1a
þ/þ (n   6) and PGC-1a
 /  (n   6) mice were
fed a high-fat diet (43% calories from fat) beginning at 4 wk of age.
Body weight was monitored weekly as shown on the graph on the left.
The mean (6 SEM) change in body weight is shown in the bar graph
on the right. *, signiﬁcant difference compared to the PGC-1a
þ/þ
controls, p , 0.05.
Found at DOI: 10.1371/journal.pbio.0030101.sg004 (794 KB EPS).
Table S1. Probes and Primers
Sequences of mouse-speciﬁc probes and primers used for real-time
RT-PCR.
Found at DOI: 10.1371/journal.pbio.0030101.st001 (25 KB DOC).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/) accession numbers of the
vector discussed in this paper is p1339-PGK-Neomycin targeting
vector (AF335420).
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